Meeting
2023 ASCO Genitourinary Cancers Symposium
Patient perspectives on the impact of immune therapy on comorbid conditions in kidney cancer.
Authors
Ulka N. Vaishampayan
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Ulka N. Vaishampayan , Michael D. Staehler , Sumanta Monty Pal , Emma Zipperer , Neil Vaishampayan , Neha Shah , Dena Battle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 640)
DOI
10.1200/JCO.2023.41.6_suppl.640
Abstract #
640
Poster Bd #
F10
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Risk of early non-cancer deaths in adults diagnosed with metastatic genitourinary (mGU) cancers: A retrospective cohort study.
First Author: Ahsan Ayaz
Poster
2023 ASCO Annual Meeting
Phase II study of cabozantinib (Cabo) with nivolumab (Nivo) and ipilimumab (Ipi) in advanced renal cell carcinoma with variant histologies (RCCvh).
First Author: Bradley Alexander McGregor
Poster
2023 ASCO Genitourinary Cancers Symposium
Differences in the tumor transcriptomic profile of patients (pts) with advanced prostate cancer (PCa) with and without diabetes mellitus (DM).
First Author: Nishita Tripathi
Poster
2023 ASCO Genitourinary Cancers Symposium
Patient characteristics, treatment patterns and outcomes for patients with renal cell carcinoma in England: A retrospective cohort study using data from the National Cancer Registry and treatment and hospital data.
First Author: Prantik Das